AU6594896A - Lipopolysaccharide endotoxin response gene and use thereof in screening agents for anti-endotoxemia activity - Google Patents

Lipopolysaccharide endotoxin response gene and use thereof in screening agents for anti-endotoxemia activity

Info

Publication number
AU6594896A
AU6594896A AU65948/96A AU6594896A AU6594896A AU 6594896 A AU6594896 A AU 6594896A AU 65948/96 A AU65948/96 A AU 65948/96A AU 6594896 A AU6594896 A AU 6594896A AU 6594896 A AU6594896 A AU 6594896A
Authority
AU
Australia
Prior art keywords
endotoxemia
activity
screening agents
response gene
lipopolysaccharide endotoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65948/96A
Inventor
Hong Chen
Anthony D. Kang
Barnet M. Sultzer
Peter M. C. Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Temple University of Commonwealth System of Higher Education
Original Assignee
Research Foundation of State University of New York
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York, Temple University of Commonwealth System of Higher Education filed Critical Research Foundation of State University of New York
Publication of AU6594896A publication Critical patent/AU6594896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/5052Cells of the immune system involving B-cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073Stem cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU65948/96A 1995-07-21 1996-07-16 Lipopolysaccharide endotoxin response gene and use thereof in screening agents for anti-endotoxemia activity Abandoned AU6594896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US132995P 1995-07-21 1995-07-21
US001329 1995-07-21
PCT/US1996/012129 WO1997004001A1 (en) 1995-07-21 1996-07-16 Lipopolysaccharide endotoxin response gene and use thereof in screening agents for anti-endotoxemia activity

Publications (1)

Publication Number Publication Date
AU6594896A true AU6594896A (en) 1997-02-18

Family

ID=21695482

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65948/96A Abandoned AU6594896A (en) 1995-07-21 1996-07-16 Lipopolysaccharide endotoxin response gene and use thereof in screening agents for anti-endotoxemia activity

Country Status (2)

Country Link
AU (1) AU6594896A (en)
WO (1) WO1997004001A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1840659A (en) * 1998-04-27 2006-10-04 联邦高等教育系统坦普尔大学 Method of treating endotoxemia

Also Published As

Publication number Publication date
WO1997004001A1 (en) 1997-02-06

Similar Documents

Publication Publication Date Title
AU7464998A (en) Melanocortin receptor ligands and methods of using same
AU4339097A (en) Carbamate-derivatized nucleosides and oligonucleosides
AU7243396A (en) Peanut allergens and methods
AU8766098A (en) Assay methods and apparatus
AU6109396A (en) Modular damper and structure with this damper
ZA963937B (en) Polysiloxane-polyol macromers their preparation and their use
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
AU4065495A (en) Particulate foam control agents and their use
GB2298807B (en) Cleaning sheet and recording medium set including the same cleaning sheet
AU7422496A (en) NM03 antibody materials and methods
AU6057296A (en) DNA sequencing and DNA terminators
GB9516059D0 (en) Novel genes and proteins
AU5044898A (en) Glycolipid mimics and methods of use thereof
AU4064897A (en) Mammalian ribonuclease inhibitors and use thereof
GB9501509D0 (en) Particulate foam control agents and their use
AUPM375094A0 (en) Cytokine receptor interactive molecules and methods for assaying cytokine function
AUPN710995A0 (en) Hydrophone and array thereof
AU2408397A (en) Ob protein receptor genes and use of the same
AU3634595A (en) Bis-oxazolidines and their use
AU5369396A (en) Rest protein and dna
AU9357598A (en) Multipurpose display and support system
IL114074A0 (en) Universal beehive support and beehive construction
AU6594896A (en) Lipopolysaccharide endotoxin response gene and use thereof in screening agents for anti-endotoxemia activity
AU4459196A (en) Sustained-release preparation and use
GB9606882D0 (en) Signal and support structure